Weidong Niu

Prof. Dr. Weidong Niu


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2020 in Cancer Letters
Verified
Journal Article
Closed access
JLJiao Li
Jiao Li
XLXue Liu
Xue Liu
SZShizhu Zang
Shizhu Zang
JZJiasheng Zhou
Jiasheng Zhou
FZFuyin Zhang
Fuyin Zhang
TLTingjiao Liu
Tingjiao Liu

1 October 2018 in Microbial Pathogenesis
Verified
Journal Article
Closed access
FSFubo Sun
Fubo Sun
AAAyaz Ahmed
Ayaz Ahmed
LWLina Wang
Lina Wang
MDMing Dong
Ming Dong
WNWeidong Niu
Weidong Niu

1 July 2016 in Journal of Endodontics
Verified
Journal Article
Closed access
PDF file
LWLina Wang
Lina Wang
HJHaiwei Jin
Haiwei Jin
DYDandan Ye
Dandan Ye
JWJiaojiao Wang
Jiaojiao Wang
XAXiang Ao
Xiang Ao
WNWeidong Niu
Weidong Niu

26 February 2021 in Frontiers in Bioengineering and Biotechnology
Verified
Journal Article
Open access
MDMing Dong
Ming Dong
SWSaixuan Wu
Saixuan Wu
HXHuijun Xu
Huijun Xu
XYXinxin Yu
Xinxin Yu
LWLina Wang
Lina Wang
WNWeidong Niu
Weidong Niu
Icariin is a class IV drug of low solubility, permeability, and poor bioavailability. Synthetic nanomaterials have developed rapidly. However, some literatures point out that synthetic nanomaterials such as liposomes, aptamers, metal nanoparticles, and nanogels have high toxicity and are affected by the reticuloendothelial system or mononuclear phagocyte system. It is known that exosomes could be used as an ideal clinical drug delivery vehicle to avoid the above-mentioned problems to a certain extent. Studies have shown that drugs can be loaded into exosomes by passive and active loading. We used Fetal bovine serum (FBS) exosomes to carry Icariin for the first time in this experiment, FBS exosomes-Icariin (FBS EXO-ICA) more effectively promoted the proliferation of osteoblasts and bone regeneration than Icariin alone. FBS EXO-ICA could become a new nano scale drug formulation for treating diseases associated with bone loss.

5 September 2018 in Cellular Physiology and Biochemistry
Verified
Journal Article
Open access
PDF file
MDMing Dong
Ming Dong
XYXinxin Yu
Xinxin Yu
WCWanfang Chen
Wanfang Chen
ZGZhenzhen Guo
Zhenzhen Guo
LSLinlin Sui
Linlin Sui
YKYing Kong
Ying Kong
Background/Aims: Periapical periodontitis is caused by bacterial infection and results in both one destruction and tooth loss. Osteopontin (OPN) is a secreted phosphorylated glycoprotein that participates in bone metabolism. Methods: Thirty-three patients with chronic periapical periodontitis and 10 patients who had undergone the orthodontic removal of healthy tooth tissue (control) at the periodontal ligament were investigated, and an animal model of mouse periapical periodontitis was established for an in vivo analysis. The relationship between OPN and bone destruction during periapical periodontitis was analyzed. Osteoblasts and osteoclasts were cultured in vitro and treated with lipopolysaccharide. An inhibitor of NF-κB was used to pretreat the transfected cells. Results: OPN increased osteoclast proliferation and differentiation, but reduced osteoblasts proliferation and differentiation. OPN activated the NF-κB pathway during periapical periodontitis and accelerated the transfer and phosphorylation of P65 from the cytoplasm to the nucleus. Conclusion: This study demonstrated that OPN played important roles in the progression of periapical periodontitis, and a dual role in bone metabolism during periapical periodontitis, linking osteoclasts and osteoblasts. The underlying mechanism may be related to the NF-κB pathway.

11 August 2022 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
PDF file
MDMing Dong
Ming Dong
CSChun Shi
Chun Shi
XYXinxin Yu
Xinxin Yu
QYQian Yang
Qian Yang
SWSaixuan Wu
Saixuan Wu
WNWeidong Niu
Weidong Niu
Small extracellular vesicles (sEVs) are an important component in the paracrine pathway. They can be used as a substitute for seed cells and have shown good application prospects in promoting bone regeneration. Cow’s milk could be used as a source of sEVs with good biocompatibility and cost-effectiveness, with easy availability, low cost and low toxicity. This study focused on the role and mechanism of small extracellular vesicles derived from milk in bone repair. In order to explore the mechanism via which Milk-sEVs promote bone repair, we screened the differential gene GJA1 in Milk-sEV-treated osteoblasts through transcriptome chips, and verified the transcript AP3B1 of GJA1 through chromatin immunoprecipitation (CHIP). We have proved by in vivo and in vitro experiments that milk-derived sEVs (Milk-sEVs) increase the repair ability of bone tissue, and promote expression of the osteogenic gene GJA1 through the transcript AP3B1. Graphical abstract